The company’s valuation has increased by $1 billion since its $130 million Series E funding round last year.

NUS Medicine’s latest model has outperformed DNA-based biological ageing clocks and demonstrated a stronger capability to predict mortality.

What they offer is not a passive but an active clinical assistant that thinks beyond consultation notes.

Wojcicki, cofounder and former CEO of 23andMe, is set to reacquire the company through her nonprofit, TTAM Research Institute.

InSilicoTrials will make use of Microsoft Azure’s cloud infrastructure and AI proficiencies to promote its digital simulation platform.

Also, VUNO has obtained regulatory clearance in South Korea for its AI-based screening solution for kidney failure.

Also, radiology reporting solutions provider Kailo Medical has acquired a clinician-founded genAI company.

The company will use the funds to increase the adoption of its new offering, Sage, across healthcare providers, payers and care management organizations.

Michael Needham, principal at Efficio, says the Trump administration’s tariffs create uncertainty and indecision for business.

The robotic puppy is made for people with dementia and mild cognitive impairment living in private homes, assisted living facilities and memory care communities.